远程医疗报告_ 2023年3月（英）

Lawrence Giesen, Partnerlawrence.giesen@drakestar.com+33 170 087 613Christophe Morvan, Managing Partner christophe.morvan@drakestar.com+33 170 087 610Antoine Pigneux, Associateantoine.pigneux@drakestar.com+33 170 087 621Joshua Acker, Analystjoshua.acker@drakestar.com+1 262 365 4419EUROPEAN & US TELEMEDICINEMARCH 2023WWW.DRAKESTAR.COMSECTOR REPORTChristophe MorvanManaging PartnerLawrence GiesenPartnerDrake Star is an award-winning global tech investment bank that has completed over 450 transactions since2003. Drake Star team of over 100 senior professionals across offices in New York, London, Paris, Munich, SanFrancisco, Los Angeles, Berlin, Miami, Dubai*, and Singapore* focuses on mergers & acquisitions andcorporate finance services worldwide in Consumer & Retail Technology, Digital Media, FinTech, Mobility &Sustainability, Software/SaaS, Digital Services, and Industrial Tech sectors.Drake Star Securities LLC is regulated by FINRA and is a member of SIPC. All securities in the UK, aretransacted through Drake Star UK Limited (FRN 942020) an appointed representative of Kession Capital Ltd(FRN 582160) which is authorized and regulated by the Financial Conduct Authority.© Copyright 2023 Drake Star Partners LimitedThis report is published solely for informational purposes and is not to be construed as an offer to sell or thesolicitation of an offer to buy any security. The information herein is based on sources we believe to be reliablebut is not guaranteed by us and we assume no liability for its use. Any opinions expressed herein are statementsof our judgment on this date and are subject to change without notice.Citations and sources are available upon request through https://www.drakestar.com/contact. Interviews wereconducted by Drake Star Partners via email correspondence between February and April 2021.Antoine PigneuxAssociateJoshua AckerAnalystABOUT THE AUTHORSEXPECTED EUROPEAN TELEMEDICINE REVENUESFROM $11BN IN 2022 TO $32BN IN 2030CLOSED IN EUROPE BETWEEN 2015 AND 2022126 M&A DEALSCLOSED IN EUROPE BETWEEN 2015 AND 2022521 PRIVATE PLACEMENTSEUROPEAN COMPANIES WITH TELEMEDICINE-RELATED ACTIVITIES+200 INVESTORS BACKING EUROPEAN TELEMEDICINE COMPANIES+400Sources: Pitchbook, CapitalIQ, Grandview Research, Drake StarCLOSED IN US BETWEEN 2015 AND 20222,193 PRIVATE PLACEMENTSCLOSED IN US BETWEEN 2015 AND 2022 278 M&A DEALSEXPECTED US TELEMEDICINE REVENUESFROM $35BN IN 2022 TO $123BN IN 2030INVESTORS BACKING US TELEMEDICINE COMPANIES+1,800US COMPANIES WITH TELEMEDICINE-RELATED ACTIVITIES+800 •We are pleased to publish a new Drake Star telemedicine sector report which presentsthe US telemedicine market alongside European telemedicine, reflecting the global natureof the sector.•After major sector upheavals driven by the COVID-19 pandemic, the telemedicine sectoris now experiencing moderate but steady growth in terms of patient utilization.Strategically speaking, M&A activity has been driven by cross-border expansion, as wellas an important focus on profi